SJ Medical
SJ Medical
Brazil represents one of the most significant markets for Drug-Eluting Stents (DES) in Latin America. With an aging population and a growing prevalence of cardiovascular diseases (CVD), the demand for high-quality interventional cardiology devices has never been higher. As a leading exporter, we recognize that the Brazilian healthcare system, divided between the SUS (Sistema Único de Saúde) and private insurance providers, requires diverse solutions ranging from cost-effective standards to cutting-edge innovations.
In major medical hubs like São Paulo, Rio de Janeiro, and Curitiba, Brazilian cardiologists are increasingly adopting polymer-free and bio-absorbable polymer DES to minimize late stent thrombosis. Our role as a global exporter is to bridge the gap between advanced R&D and local clinical needs, ensuring that Brazilian clinics have access to the same technology used in Europe and North America.
The industrial landscape in Brazil is shifting towards localized distribution and rigorous ANVISA (Agência Nacional de Vigilância Sanitária) compliance. Exporters must navigate complex regulatory frameworks to prove the safety and efficacy of their stent systems. Our Sirolimus-eluting stents are engineered to meet these exacting standards, offering a balanced elution profile that promotes rapid endothelialization.
Key trends we observe in the Brazilian market include:
Our Ht-Supreme system is specifically designed to address these trends, providing a "Healing-Targeted" approach that suits the Brazilian clinical focus on long-term patient outcomes.
Established in 2015, Hangzhou SJ Medical Co., Ltd. has rapidly emerged as a pioneer in the vascular interventional field. Our expertise lies in the full lifecycle of medical device production—from initial R&D and precision manufacturing to global commercialization. We specialize in both cardiovascular and peripheral interventions, delivering solutions that are not only technologically advanced but also safe and reliable.
Our state-of-the-art facility operates under strict GMP standards, featuring million-class clean workshops and localized hundred-class zones for critical assembly. This meticulous attention to detail is why we are a trusted Drug-Eluting Stents (DES) exporter to Brazil and other sophisticated markets worldwide.
Providing high-volume, reliable stent systems that offer excellent cost-performance ratios for government-funded cardiovascular programs across Brazil.
Supplying premium, polymer-free technologies for high-end hospitals in São Paulo and Rio, where patients demand the latest global innovations.
Extending care beyond the heart with guidewires and balloon catheters designed for diabetic foot treatment and other peripheral vascular diseases prevalent in the region.
What sets SJ Medical apart in the Brazilian market is our commitment to Sirolimus-Eluting technology. Unlike traditional paclitaxel-coated options, Sirolimus offers a broader therapeutic window and better safety profile regarding late-term restenosis. Our stents feature:
Our R&D team consists of industry veterans with decades of experience, ensuring that every product exported to Brazil is backed by deep scientific expertise and clinical validation.
Exporting medical devices to Brazil requires more than just high-quality products; it requires a partner who understands the logistics, the regulatory environment, and the clinical expectations of the Brazilian medical community. We offer:
We provide full documentation and technical files required for ANVISA registration, simplifying the import process for Brazilian distributors.
With established partnerships across Europe and Asia, we have mastered the cold-chain and sterile logistics necessary for delicate interventional devices.
We offer comprehensive support and training materials for local sales teams in Brazil to ensure they can effectively communicate the benefits of our stent systems to clinicians.
Our mission is to improve patient lives through innovation. By combining our manufacturing prowess with a deep understanding of the Brazilian cardiovascular market, we stand as a premier exporter ready to support the next generation of interventional care.
